Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267
Wall Street
Price Targets
Price Targets Summary
Zhejiang Hisun Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Zhejiang Hisun Pharmaceutical Co Ltd is 7.65 CNY with a low forecast of 7.58 CNY and a high forecast of 7.88 CNY.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Zhejiang Hisun Pharmaceutical Co Ltd's stock price target?
Price Target
7.65
CNY
According to Wall Street analysts, the average 1-year price target for Zhejiang Hisun Pharmaceutical Co Ltd is 7.65 CNY with a low forecast of 7.58 CNY and a high forecast of 7.88 CNY.
What is Zhejiang Hisun Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
1%
For the last 13 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's revenue is 5%. The projected CAGR for the next 3 years is 1%.
What is Zhejiang Hisun Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-4%
For the last 13 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's operating income is 3%. The projected CAGR for the next 3 years is -4%.
What is Zhejiang Hisun Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-2%
For the last 13 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's net income is 1%. The projected CAGR for the next 3 years is -2%.